Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001641172-25-010196·60 DEGREES PHARMACEUTICALS, INC.
Schedule 13G ownership disclosure
60 DEGREES PHARMACEUTICALS I
Common stock, par value $0.0001 per share · CUSIP: 83006G401
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Ayrton Capital LLC
Shares: 163,480.00 · Class: 9.99%
- Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B
Shares: 163,480.00 · Class: 9.99%
- Waqas Khatri
Shares: 163,480.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001641172-25-010196
- Form type
- SCHEDULE 13G
- Filer
- 60 DEGREES PHARMACEUTICALS, INC.
- CIK
- CIK 1946563
- Filed
- May 14, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership